Calcineurin Inhibitors, Macrolides, and the Risk of Adverse Drug Events in Kidney Transplant Recipients.

被引：0
|
作者：
Jeong, R. [1 ]
Quinn, R. [2 ]
Ravani, P. [2 ]
Lentine, K. [3 ]
Lloyd, A. [1 ]
Hemmelgarn, B. [2 ]
Wen, K. [1 ]
Braam, B. [1 ]
Gourishankar, S. [1 ]
Wong, A. [1 ]
Lam, N. [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
[2] Univ Calgary, Calgary, AB, Canada
[3] St Louis Univ, St Louis, MO 63103 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C115
引用
收藏
页码：807 / 807
页数：1
相关论文
共 50 条
  • [1] Conversion of calcineurin inhibitors to sirolimus in liver transplant recipients.
    Mies, Sergio
    Beduschi, Thiago
    Silva, Vinicius M. R.
    Mies, Ana Olga N. G. F.
    Della Guardia, Bianca
    Baia, Carlos E. S.
    de Almeida, Marcio D.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (06) : S189 - S189
  • [2] Unexpected Early Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
    Yanik, M.
    Mannon, R.
    Seifert, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 750 - 750
  • [3] Calcineurin Inhibitor Dosing Requirements in HIV Positive Kidney Transplant Recipients.
    Sievers, Theodore M.
    Emami, Sina
    Wilkinson, Alan
    Danovitch, Gabriel
    Pham, Phuong-Thu
    Bunnapradist, Suphamai
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 398 - 398
  • [4] Medication Errors and Adverse Drug Events in Kidney Transplant Recipients: Incidence, Risk Factors, and Clinical Outcomes
    Taber, David J.
    Pilch, Nicole A.
    Bratton, Charles F.
    McGillicuddy, John W.
    Chavin, Kenneth D.
    Baliga, Prabhakar K.
    [J]. PHARMACOTHERAPY, 2012, 32 (12): : 1053 - 1060
  • [5] A racial comparison of the adverse effects of sirolimus in kidney transplant recipients.
    Taber, DJ
    Baillie, GM
    Ashcraft, EE
    Berkman, S
    Lin, A
    Chavin, KD
    Baliga, PK
    Rogers, J
    Rajagopalan, PR
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 225 - 225
  • [6] The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
    Emel Isiktas Sayilar
    Alparslan Ersoy
    Canan Ersoy
    Aysegul Oruc
    Yavuz Ayar
    Deniz Sigirli
    [J]. BMC Nephrology, 23
  • [7] The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
    Sayilar, Emel Isiktas
    Ersoy, Alparslan
    Ersoy, Canan
    Oruc, Aysegul
    Ayar, Yavuz
    Sigirli, Deniz
    [J]. BMC NEPHROLOGY, 2022, 23 (01)
  • [8] Impact of Induction Therapy on Cardiovascular Events in Kidney Transplant Recipients.
    Sandal, S.
    Bae, S.
    Massie, A.
    Cantarovich, M.
    Segev, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 208 - 209
  • [9] MATHEMATICAL MODEL FOR ADVERSE CARDIOVASCULAR EVENTS RISK ASSESSMENT IN KIDNEY TRANSPLANT RECIPIENTS
    Smaliakova, Maria
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I962 - I962
  • [10] Comparison of Statin-Associated Adverse Events Across Different Types of Statins in Kidney Transplant Recipients.
    Bae, S.
    Ahn, J.
    Schnitzler, M. A.
    Lentine, K.
    Segev, D.
    McAdams-DeMarco, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 683 - 683
12345